Polyneuropathy (peripheral)

G62.9
alcoholicG62.1
amyloid (Portuguese)E85.1
amyloid (Portuguese), transthyretin-related (ATTR) familialE85.1
arsenicalG62.2
critical illnessG62.81
demyelinating, chronic inflammatory (CIDP)G61.81
diabeticSee Diabetes, polyneuropathy
drug-inducedG62.0
hereditaryG60.9
hereditary, specified NECG60.8
idiopathicG60.9
idiopathic, progressiveG60.3
in (due to)
in (due to), alcoholG62.1
in (due to), alcohol, sequelaeG65.2
in (due to), amyloidosis, familial (Portuguese)E85.1
in (due to), antitetanus serumG61.1
in (due to), arsenicG62.2
in (due to), arsenic, sequelaeG65.2
in (due to), avitaminosis NECE56.9
in (due to), beriberiE51.11
in (due to), collagen vascular disease NECM35.9
in (due to), deficiency (of)
in (due to), deficiency (of), B (-complex) vitaminsE53.9
in (due to), deficiency (of), vitamin B6E53.1
in (due to), diabetesSee Diabetes, polyneuropathy
in (due to), diphtheriaA36.83
in (due to), drug or medicamentG62.0
in (due to), drug or medicament, correct substance properly administeredSee Table of Drugs and Chemicals, by drug, adverse effect
in (due to), drug or medicament, overdose or wrong substance given or takenSee Table of Drugs and Chemicals, by drug, poisoning
in (due to), endocrine disease NECE34.9
in (due to), herpes zosterB02.23
in (due to), hypoglycemiaE16.2
in (due to), infectious
in (due to), infectious, disease NECB99
in (due to), infectious, mononucleosisB27.91
in (due to), lack of vitamin NECE56.9
in (due to), leadG62.2
in (due to), lead, sequelaeG65.2
in (due to), leprosyA30.9
in (due to), Lyme diseaseA69.22
in (due to), metabolic disease NECE88.9
in (due to), microscopic polyangiitisM31.7
in (due to), mumpsB26.84
in (due to), neoplastic diseaseD49.9
in (due to), nutritional deficiency NECE63.9
in (due to), organophosphate compoundsG62.2
in (due to), organophosphate compounds, sequelaeG65.2
in (due to), parasitic disease NECB89
in (due to), pellagraE52
in (due to), polyarteritis nodosaM30.0
in (due to), porphyriaE80.20
in (due to), radiationG62.82
in (due to), rheumatoid arthritisSee Rheumatoid, polyneuropathy
in (due to), sarcoidosisD86.89
in (due to), serumG61.1
in (due to), syphilis (late)A52.15
in (due to), syphilis (late), congenitalA50.43
in (due to), systemic
in (due to), systemic, connective tissue disorderM35.9
in (due to), systemic, lupus erythematosusM32.19
in (due to), toxic agent NECG62.2
in (due to), toxic agent NEC, sequelaeG65.2
in (due to), transthyretin-related (ATTR) familial amyloidE85.1
in (due to), triorthocresyl phosphateG62.2
in (due to), triorthocresyl phosphate, sequelaeG65.2
in (due to), tuberculosisA17.89
in (due to), uremiaN18.9
in (due to), vitamin B12 deficiencyE53.8
in (due to), vitamin B12 deficiency, with anemia (pernicious)D51.0
in (due to), vitamin B12 deficiency, with anemia (pernicious), due to dietary deficiencyD51.3
in (due to), zosterB02.23
inflammatoryG61.9
inflammatory, chronic demyelinating (CIDP)G61.81
inflammatory, sequelaeG65.1
inflammatory, specified NECG61.89
leadG62.2
lead, sequelaeG65.2
nutritional NECE63.9
postherpetic (zoster)B02.23
progressiveG60.3
radiation-inducedG62.82
sensory (hereditary) (idiopathic)G60.8
specified NECG62.89
syphilitic (late)A52.15
syphilitic (late), congenitalA50.43